Download Curriculum Vitae - Armenian EyeCare Project

February 1, 2007
CURRICULUM VITAE
Steven Elliott Feldon, MD, MBA
A. PERSONAL INFORMATION:
Business Address
University of Rochester
601 Elmwood Avenue
Department of Ophthalmology
Box 659
Rochester, New York 14642
Business Telephone
(585) 275-1126
Business Fax
(585) 273-1043
E-mail Address
[email protected]
Date of Birth
February 17, 1948
Place of Birth
Los Angeles, California
Citizenship
USA
Marital Status
Married
Spouse's First Name
Diane
Number of Children
Three
B. EDUCATION:
High School
Beverly Hills High School
Graduation - 1965
College or University
University of California
Los Angeles, California
BA (Psychology) - 1969
Graduate School
University of Southern California
Marshall School of Business Administration
Los Angeles, California
MBA - 1997
Medical School
Yeshiva University
Albert Einstein College of Medicine
Bronx, New York
MD – 1973
CURRICULUM VITAE
PAGE 2
STEVEN E. FELDON, MD
Internship
Straight Medicine
University of California Medical Center
Los Angeles, California
Dates: 1973 - 1974
Residencies
Resident in Ophthalmology
Massachusetts Eye and Ear Infirmary
Boston, Massachusetts
Dates: 1975 - 1978
Fellowships
Research Fellow in Neurosurgery
Massachusetts General Hospital
Boston, Massachusetts
Dates: 1974 - 1975
Clinical Fellow
Harvard Medical School
Ophthalmology Department
Cambridge, Massachusetts
Dates: 1976 - 1978
Clinical Fellow
(Neuro-Ophthalmology)
University of California, San Francisco
San Francisco, California
Dates: 1978 - 1979
Honors and Awards
Alpha Omega Alpha
Honor Medical Society
Date: 1973
Beta Gamma Sigma
Business Honor Society
Dates: 1997
Post-Doctoral Research Training Award
National Eye Institute
Fellowship #1 F32 EY05303-01
Dates: 1978 - 1979
Heed Fellowship (Declined in order to accept NIH Award)
Dates: 1978 - 1979
Listed -- “The Best Doctors in America”
Ophthalmology and Neurology Sections
Dates: 1994, 1996, 1998, 2000, 2002, 2003, 2004, 2005, 2006
Listed -- “America’s Top Doctors”
Dates: 2001-2006
CURRICULUM VITAE
PAGE 3
STEVEN E. FELDON, MD
Distinguished Senior Award
NANOS
Dates: 2005
Senior Honor Award
AAO
Dates: 2005
Current Licensure
California: G027884
1974
New York: 222798
2001
Board Certification
American Board of Ophthalmology
May 20, 1979
C. PROFESSIONAL BACKGROUND:
Academic Appointment
Professor, Ophthalmology, Neurology, Neurological Surgery, and Visual Science, University
of Rochester 2001-present; Chair, Department of Ophthalmology, University of Rochester
2001 – present, and Director, University of Rochester Eye Institute 2002 - present
Professor, Ophthalmology and Neurological Surgery, University of Southern California
School of Medicine, Los Angeles, California, 1992 – 2001
Associate Professor, Ophthalmology and Neurological Surgery, University of Southern
California School of Medicine, Los Angeles, California, 1983 - 1992
Assistant Professor, Ophthalmology and Neurological Surgery, University of Southern
California School of Medicine, Los Angeles, California, 1979 - 1983
Specific teaching responsibilities
Preceptor to undergraduate students, graduate students, and medical students doing research in
ophthalmology, on-going.
Supervision of Neuro-ophthalmology rounds weekly, on going.
Outside member of doctoral thesis committee, University of Arizona, 1982
Director for Medical Students Training in Ophthalmology, University of Southern California
School of Medicine, Los Angeles, California, 1979-1985
Member of doctoral thesis committee for University of Southern California School of
Medicine, Department of Psychology, 1982.
Member of the Faculty, Section V (Neuro-Ophthalmology), Basic and Clinical Science
Course, American Academy of Ophthalmology 1982 - 1988 (Chairman 1986 - 1988)
CURRICULUM VITAE
PAGE 4
STEVEN E. FELDON, MD
Specific administrative responsibilities
CURRENT
Member of Rochester Institute For Clinical and Community Health Sciences Subcommittee
on clinical trials, University of Rochester, Rochester, NY. 2003-present.
Member of Strategic Planning Task Force: Basic Science Research Committee (Neuroscience
Subcommittee), University of Rochester, Rochester, NY. 2005 – present.
Member of Credentials and Privilege Review Committee. University of Rochester, Rochester,
NY. 2003-present.
Member of Research Advisory Committee. University of Rochester, Rochester, NY. 2003present.
Member of Intellectual Property Advisory Committee. University of Rochester, Rochester,
NY. 2005 – present.
Member of URMC Board. 2006-present.
PAST
Member of University of Rochester Medical Faculty Group Executive Committee, University
or Rochester, Rochester, NY. 2004- 2005.
Member of MEDSAC Steering Committee, University Of Rochester, Rochester, N.Y. 20022005.
Strategic Planning Task Force: Clinical Care Committee, University of Rochester, Rochester,
NY. 2003-2005.
Medical Director, Department of Ophthalmology, Chapman Medical Center, Orange,
California, 1999 –2001
Medical Director, Pearle Vision Care Optometric, San Diego, California, 1997 - 2001
Vice President, Business Development, Doheny Eye Medical Group, Inc., Los Angeles,
California, 1996 –2001
Associate Chairman, Department of Ophthalmology, University of Southern California
School of Medicine, Los Angeles, California, 1996- 2001
Member of Finance Committee, University of Southern California School of Medicine, Los
Angeles, California, 1995 - 2001
Member of Year IV Elective Committee, University of Southern California School of
Medicine, Los Angeles, California, 1985 - 2001
Treasurer, Doheny Eye Medical Group, Inc., Los Angeles, California, 1983 - 2001
Member of Executive Committee, Doheny Eye Medical Group, Inc., Los Angeles, California,
1984 - 2001
Member of University Hospital Administration Committee, University of California School of
Medicine, Los Angeles, California
Member of Steering Committee for Doheny Eye Institute, Los Angeles, California
Chairman, Professional Services Committee for Estelle Doheny Eye Hospital, Los Angeles,
California, 1988 - 1990
Member of Quality Improvement Council, Doheny Eye Institute, Los Angeles, California,
1991 - 1993
Member of USCP Managed Care Committee, USC University Hospital, Los Angeles,
California, 1991 - 1993
Member of USCP Liaison Committee, USC University Hospital, Los Angeles, California,
1991 - 1993
Member of Office of the Chief Operating Officer, Doheny Eye Institute, Los Angeles,
California, 1990 - 1992
CURRICULUM VITAE
PAGE 5
STEVEN E. FELDON, MD
Member of Administration Committee for Estelle Doheny Eye Medical Clinic, Inc., Los
Angeles, California, 1986 - 1991
Chief of Staff, Estelle Doheny Eye Hospital, Los Angeles, California, 1991 - 1995
Chief of Service, USC University Hospital, Los Angeles, California, 1995 – 1996; 1998-2001
Hospital Affiliations
Huntington Memorial Hospital
LAC/USC Medical Center
Childrens’ Hospital of Los Angeles
Kenneth Norris, Jr. Cancer Hospital
Estelle Doheny Hospital
USC University Hospital
City of Hope
Strong Memorial Hospital
Highland Hospital
1979 - 1997
1979 - 2001
1979 - 2001
1983 - 2001
1985 - 1995
1991 - 2001
1996 - 2001
2001 - present
2005 - present
Military Service
None
Other activities
President, Eye-Deas, L.L.C. Research and Development Company, 2001-present
Chief Executive Officer and Chairman, Documation, Inc., Los Angeles, California,
1993 – 1997
Managing Partner, Doheny Equipment Partnerships #1 and #2, Estelle Doheny Eye Medical
Clinic, Inc., Los Angeles, California, 1982 -1989
General Partner, Automated Ophthalmic Research and Development Partnership, Glendale,
California, 1984 – 1988
Chief Executive Officer, Oculab, Inc., Glendale, California, 1984 - 1988
Partner, Design Team Partners, Oculab, Inc., Glendale, California, 1982 - 1988
General Partner, Keratometer Research and Development Partnership, Oculab, Inc., Glendale,
California, 1982 - 1988
D. SOCIETY MEMBERSHIPS:
Local
Medical Society of the State of New York, 2002-Present
New York State Ophthalmological Society, 2002-Present
California Association of Ophthalmology, 1982 - 2001
California Medical Association, 1989 - 1995
Doheny - USC Professional Association, 1995 – Present
Massachusetts Eye & Ear Infirmary Alumni Association, 1978 – Present
National and International
American Ophthalmology Society, 2005 – Present
- Program Committee, 2006-Present
Editorial Advisory Board of Ocular Surgery News, 2002 – Present.
Association of University Professors of Ophthalmology, 2001-Present
- Fellowship Accreditation Committee, 2004 – Present.
Associate Examiner, American Board of Ophthalmology, 1996-Present
CURRICULUM VITAE
PAGE 6
STEVEN E. FELDON, MD
- Senior Mentor, 2003, 2005
Pan American Association of Ophthalmology, 1989 – 1995
International Society for Orbital Disorders, 1980 - 1995
North American Neuro-Ophthalmology Society, 1983 – Present
- Board member : 1992-2000
- President: 1994-96
- Chair of the Board: 1998-2000
- Facilitator Strategic Planning: 1999,2001, 2003
- Fellowship Training Committee: 2002-Present
- Publications Committee Member: 2003-Present
- Finance Committee Member: 2003-Present
- Accreditation Committee, Chair
- Credentials Committee, Chair: 2003-Present
- Research Committee: 2002-Present
Beta Gamma Sigma, 1997-Present
American Academy of Ophthalmology, 1979 - Present
Association for Research in Vision and Ophthalmology, 1975 - Present
Alpha Omega Alpha, 1973 – Present
E.
PEER REVIEW ACTIVITIES
NIH ad hoc review Committees, 2001-Present
Journals:
- American Journal of Ophthalmology
- Archives of Ophthalmology
- British Journal of Ophthalmology
- Comprehensive Ophthalmology
- Graefe’s Archive for Clinical and Experimental Ophthalmology
- Investigative Ophthalmology & Visual Science
- Journal of Neuro Ophthalmology
- Journal of Neuroscience Method
- Neurology
- Ophthalmic Plastic and Reconstructive Surgery
- Ophthalmic Surgery, Lasers, and Imaging
- Ophthalmologic and Physiological Optics
- Ophthalmology
- PIER
Section Editor “Neuro-Sciences”, Ocular Surgery News, 1997 – Present
Research to Prevent Blindness ad hoc Committee, March 2004
Examiner American Board of Ophthalmology, 1996 - Present
- Senior Mentor
- Props Committee
NIH Study Section – Code: BDCN-F12, 2005 - Present
F.
CONSULTING POSITIONS
Consultant, Marco Ophthalmics, 1999 - present
CURRICULUM VITAE
PAGE 7
STEVEN E. FELDON, MD
Consultant, Prudential Insurance, 1996
Medical Director, Pearle Vision Care of California, 1995 - 2001
Consultant, DICON, Inc., 1995
Consultant, Biorad Laboratories, Glendale, California, 1988 - 1992
G.
RESEARCH ACTIVITIES
Major Areas of Research Interest
Computer Applications to Eye Research
Clinical Quantitation of Abnormalities of the Visual and Oculomotor Systems
Graves' Ophthalmopathy
Research in Progress
A. Laboratory Research
1. Immunology of Graves' ophthalmopathy
B. Clinical Research
1. Evaluation and treatment of Graves' ophthalmopathy
2. Evaluation and treatment of anterior ischemic optic neuropathy
3. Quantitative analysis of fundus photographs and visual fields in non-ischemic
optic neuropathy
4. Developing clinical trial for idiopathic intracranial hypertension
5. Photography Reading Center for neuro-opthalmic and retinal disease
Research Grants Awarded
PRESENT
1. Boehringer Ingelheim Pharmaceuticals, Inc. Fundus Photography Reading Center (P.I):
Mirapex
11/04-4/07
$ 332,144
Expert Panel
$ 25,000
2. A Novel in Vitro Model of Thyroid Ophthalmopathy (P.I.) – 5 R03 EY014564-03
04/1/03-04/30/07
$ 472,500
3. Role of T Cells and PPARgamma in Graves’ Orbital Fibroblast Adipongenesis (Co-P.I.)
1 R01EY017123-01
09/05/06-08/31/2011
$. 405,000
PAST
1. Clinical Techniques Quantifying Graves' Ophthalmopathy
National Institute of Health - #RO1 EY03908
9/30/81 - 8/31/84
$ 156,891
7/1/86 - 1/14/89
$ 40,000
2. Neuronal Degeneration in the Visual System of Alzheimer's Disease Patients
National Institute of Health - #RO1 AGO5142
Visual Assessment Project:
Motor Testing, Sub-Project Director
7/1/89 - 3/31/97
$ 112,283
CURRICULUM VITAE
PAGE 8
STEVEN E. FELDON, MD
3.
Ischemic Optic Neuropathy Decompression Trial (IONDT)
National Institute of Health - Assignment #: 1U10EY09557-01
6/15/92 - 5/31/96
4. Ischemic Optic Neuropathy Decompression Trial (IONDT)
Follow-up Study (Fundus Photography and Visual Field Analysis)
National Institute of Health - Assignment # 5U10EY09557-04
12/1/96 - 11/30/00.
5. Interdisciplinary Zumberg Research Grant (individual grant),
In-Vitro and Animal Model of Graves’ Ophthalmopathy based on
Autologous Mixed Cell Reactions
07/01/2001 – 06/30/2002
6. Analysis of IONDT Visual Fields “IONDT Follow-up Study
Visual Field Analysis” - # 3 U10EY09608-10S1
02/01/02-01/31/04
$
422,646
$
458,053
$
41,000
$
83,378
CURRICULUM VITAE
PAGE 9
STEVEN E. FELDON, MD
H. BIBLIOGRAPHY
Peer Review
1. Feldon SE, Feldon P, and Kruger L: Topography of the retinal projection upon the superior
colliculus of the cat. Vis Res 10:135 - 143, 1970.
2. Feldon SE and Langston JW: Square-wave jerks: A disorder of microsaccades? Neurology
27:278 - 281, 1977.
3. Feldon SE, Renna T, and Weiss H: Amaurosis fugax due to isolated atherosclerotic carotid
artery disease in a young woman. Ann Neurol 2:541 - 542, 1977.
4. Pollen DA, Andrews BW, and Feldon SE: Spatial frequency selectivity of periodic complex
cells in the visual cortex of the cat. Vis Res 18:665 - 682, 1978.
5. Feldon SE, Andrews BW, and Pollen DA: Periodic complex cells in cortical area 19 of the
cat. Vis Res 18:347 - 350, 1978.
6. Feldon SE, Sigelman J, Albert DM, and Smith TR: Clinical manifestations of brawny
scleritis. Am J Ophthalmol 85:781 - 787, 1978.
7. Pollen DA and Feldon SE: Spatial periodicities of periodic complex cells in the visual cortex
cluster at one-half octave intervals. Invest Ophthalmol Vis Sci 18:429 - 434, 1979.
8. Arruga J, Feldon SE, Hoyt WF, and Aminoff MJ: Monocularly and binocularly evoked
visual responses to patterned half-field stimulation. J Neurol Sci 46:281 - 290, 1980.
9. Feldon SE, Hoyt WF, and Stark L: Disordered inhibition in internuclear ophthalmoplegia:
Analysis of eye movement recordings with computer simulations. Brain 103:113 - 137,
1980.
10. Ronner SF, Foote WE, and Feldon SE: Activation of single cells in cat visual cortex by
electrical stimulation of the cortical surface. Exp Neurol 70:47 - 64, 1980.
11. Stahl SM, Layzer RB, Aminoff MJ, Townsend JJ, and Feldon SE: Continuous cataplexy in a
patient with a midbrain tumor: The limp man syndrome. Neurology 30:1115 - 1118, 1980.
12. Unsold R, Feldon S, and Newton FH: On the diagnosis of extraocular muscle disease.
Clinical application of computer reformations. Klin Monatsbl Augenheilkd 178:436 - 438,
1981.
13. Feldon SE, O'Donnell JJ, and Sipila I: Eye movement recordings in gyrate atrophy of the
retina. Exp Eye Res 34:293 - 295, 1982.
14. Feldon SE, and Unsold R: Graves' ophthalmopathy evaluated by infrared eye-movement
recordings. Arch Ophthalmol 100:324 - 328, 1982.
15. Jarus GD, and Feldon SE: Clinical and computed tomographic findings in the Foster
Kennedy syndrome. Am J Ophthalmol 93:317 - 322, 1982.
16. Fastenberg DM and Feldon SE: Reversible choroidal vascular insufficiency without
infarction in temporal arteritis. Graefe's Arch Clin Exp Ophthalmol 218:327 - 330, 1982.
17. Feldon SE and Weiner JM: Clinical significance of extraocular muscle volumes in Graves'
ophthalmopathy: A quantitative computed tomography study. Arch Ophthalmol 100:1266 1269, 1982.
18. Feldon SE, Stark L, Lehman SL, and Hoyt WF: Oculomotor effects of intermittent
conduction block in myasthenia gravis and Guillain-Barré syndrome. Arch Neurol 39:497 503, 1982.
19. LoBue TD and Feldon SE: Reverse Collier's sign: Pseudoblepharoptosis associated with
downgaze paralysis. Am J Ophthalmol 95:120 - 121, 1983.
20. Traustason OI and Feldon SE: Cause of enophthalmos secondary to maxillary sinus
mucocele. Am J Ophthalmol 95:838 - 840, 1983.
CURRICULUM VITAE
PAGE 10
STEVEN E. FELDON, MD
21. Bell JA and Feldon SE: Retinal microangiopathy: Correlatin of OCTOPUS perimetry with
fluorescein angiography. Arch Ophthalmol 102:1294 - 1298, 1984.
22. Feldon SE, Muramatsu S, and Weiner JM: Clinical classification of Graves' ophthalmopathy:
Identification of risk factors for optic neuropathy. Arch Ophthalmol 102:1469 - 1472, 1984.
23. Feldon SE, Lee CP, Muramatsu SK, and Weiner JM: Quantitative computed tomography of
Graves' ophthalmopathy: Extraocular muscle and orbital fat in development of optic
neuropathy. Arch Ophthalmol 103:213 - 215, 1985.
24. Truong DM and Feldon SE: Sources of artifact in infrared recording of eye movement.
Invest Ophthalmol Vis Sci 28:1018 - 1022, 1987.
25. Ormerod LD, Weber AL, Rauch SD, and Feldon SE: Ophthalmic manifestations of maxillary
sinus mucoceles. Ophthalmol 94:1013 - 1019, 1987.
26. Traustason OI, Feldon SE, Leemaster JE, and Weiner JM: Anterior ischemic optic
neuropathy: Classification of field defects by OctopusTM automated static perimetry.
Graefs Arch Clin Exp Ophthalmol 226:206 - 212, 1988.
27. Moore LD, Feldon SE, and Liu SK: Infrared oculography of Duane's retraction syndrome
(type 1). Arch Ophthalmol 106:943 - 946, 1988.
28. Hallin ES and Feldon SE: Graves' ophthalmopathy: I. Simple CT estimates of extraocular
muscle volume. Br J Ophthalmol 72:674 - 677, 1988.
29. Hallin ES and Feldon SE: Graves' ophthalmopathy: II. Correlation of clinical signs with
measures derived from computed tomography. Br J Ophthalmol 72:678 - 682, 1988.
30. Hallin ES, Feldon SE, and Luttrell J: Graves' ophthalmopathy: III. Effect of transantral
orbital decompression on optic neuropathy. Br J Ophthalmol 72:683 - 687, 1988.
31. Feldon SE: Discussion of: Methylprednisolone pulse therapy in severe dysthyroid optic
neuropathy. Guy JR, Fagien S, Donovan JP, and Rubin ML. Ophthalmol 96:1048 - 1053,
1989.
32. Wan WL, Geller JL, Feldon SE, and Sadun AA: Visual loss caused by rapidly progressive
intracranial meningiomas during pregnancy. Ophthalmol 97:18 - 21, 1990.
33. Feldon SE and Levin L: Graves' ophthalmopathy: V. Aetiology of upper eyelid retraction in
Graves' ophthalmopathy. Br J Ophthalmol 74:484 - 485, 1990.
34. Feldon SE, Levin L, and Liu SK: Graves' ophthalmopathy: correlation of saccadic eye
movements with age, presence of optic neuropathy, and extraocular muscle volume. Arch
Ophthalmol 108:1568 - 1571, 1990.
35. Feldon SE: Graves' ophthalmopathy: Is it really a thyroid disease? Editorial. Arch Int Med
150:948 - 950, 1990.
36. Feldon SE: Macular degeneration secondary to benign orbital mass. Orbit 10:1 - 3, 1991.
37. Hudson HL, Levin LB, and Feldon SE: Graves' exophthalmos unrelated to extraocular
muscle enlargement: superior rectus muscle inflammation may induce venous obstruction.
Ophthalmol. 98:1495-1499, 1991.
38. Hudson HL, Rissell C, Gauderman WJ, and Feldon SE: Pituitary tumor volume as a
predictor of postoperative visual field recovery: quantitative analysis using automated static
perimetry and CT morphometry. J Clin Neuro-ophthalmol. 11:280-283, 1991.
39. Kwitko S, Feldon SE, McDonnell PJ: Corneal topographic changes following strabismus
surgery and Graves' disease. Cornea. 11:36-40, 1992.
40. Nassif PS, Feldon SE: Orbital lymphoma in a patient with Felty's syndrome. Br J
Ophthalmol. 764(3):173-174, 1992.
41. Hudson HL, Feldon SE: Late Overcorrection of Hypotropia in Graves' Ophthalmopathy:
Predictive Factors. Ophthalmol. 99:356-360, 1992.
CURRICULUM VITAE
PAGE 11
STEVEN E. FELDON, MD
42. DuBois LG, and Feldon SE: Evidence for a metabolic trigger for Leber's hereditary optic
neuropathy: A case report. J Clin Neuro-ophthalmol. 12(1):15-16, 1992.
43. Aiello A, Sadun AA, Feldon SE: Spontaneous Improvement of Progressive AION: A Report
of Two Cases. Arch Ophthalmol. 110:1197-1199, 1992.
44. Liu D, and Feldon SE: Thyroid Ophthalmopathy. Ophthalmol Clin N Am. 5(3):597-622,
1992.
45. Erzurum SA, Melen O, Lissner G, Friedman DI, Sadun AA, Feldon SE, and Rao NA: Orbital
Malignant Peripheral Nerve Sheath Tumors: Treatment with Surgical Resection and
Radiation Therapy. J Clin Neuro-ophthalmol. 13(1):1-7, 1993.
46. Feldon SE, Levin L, Gauderman WJ, and Barlow W: Psychological, Social, and Economic
Consequences of Graves' Ophthalmopathy. Pacific Coast Oto-Ophthalmol Soc, 1993.
47. Jungschaffer DA, Saber E, Zimmerman KM, McDonnell PJ, and Feldon SE: Refractive
changes induced by electrocautery of the Rabbit anterior lens. J Cataract Refract Surg.
20:132-137, 1994.
48. Rismondo V, Gierow JP, Lambert RW, Golchini K, Feldon SE, and Mircheff AK: Rabbit
lacrimal acinar cells in primary culture. Morphology and acute responses to cholinergic
stimulation. Invest Ophthalmol Vis Sci. 35(3):1176-1183, 1994.
49. Chou PI, and Feldon SE: Late onset dysthyroid optic neuropathy. Thyroid. 4(2):213-216,
1994.
50. Silverman SE, Tran DB, Zimmerman KM, and Feldon SE: Dissociation between the
detection and perception of motion in Alzheimer’s disease. Neurology. 44(10):1814-1818,
1994. AG05142 (National Institute of Aging).
51. The Ischemic Optic Neuropathy Decompression Trial Research Group. Optic Nerve
Decompression Surgery for Nonarteritic Ischemic Optic Neuropathy (NAION) is not
effective and may be harmful. JAMA. 273(8):625-632, 1995. EY09557-03SI.
52. Söylev MF, Green RE, Feldon SE: Choroidal effusion as a mechanism for transient myopia
induced by hydrochlorodiazide and triamterene combination. Am J Ophthalmol. 120(3):395397, 1995.
53. Saber E, McDonnell J, Yugar JE, Zimmerman KM, and Feldon SE: Extraocular muscle
changes in experimental orbital venous stasis: some similarities to Graves' orbitopathy.
Graefe’s Arch Clin Exp Ophthalmol, 234:331-336, 1996.
54. Sadun F, Feldon SF, Weiss MH, Krieger MD. Cavernous sinus thrombosis following
transspenoidal craniotomy. J Neurosurg, 85:949-952, 1996.
55. Hudson HL, Hinton DR, Friedman DI, Apuzzo M, Chandrasoma P, Garbut M, Feldon SE.
Pseudotumor associated with CNS lymphoma. J Neuro-Ophthalmol, 16(3):208-211, 1996.
56. WuDunn D, Zimmerman KM, Sadun AA, Feldon SE. Comparison of visual function in
fellow eyes after bilateral non-arteritic anterior ischemic optic neuropathy. Ophthalmol,
104(1):104-111, 1997.
57. Tran DB, Silverman SE, Zimmerman KM, Feldon SE. Age-related deterioration of motion
perception and detection. Graefe’s Arch Clin Exp Ophthalmol, 236:269-273, 1998.
58. Liu NH, LaBree LD, Feldon SE, Rao NA: The Epidemiology of Giant Cell Arteritis. A 12Feldon SE. Anterior Ischemic Optic Neuropathy: Trouble Waiting To Happen. Opthalmol,
106:651-652, 1999.
59. Wang MY, Sadun F, Levin LB, LaBree L, and Feldon SE. Occurrence and clinical profile of
familial non-arteritic optic neuropathy. J Neuro-Ophthalmol, 19:144-147, 1999.
60. Chou PI, Chang YS, Feldon SE, Chen JT. Optic canal mucocele from anterior clinoid
pneumatisation. Br J Ophthalmol, 83:1306-7, 1999.
CURRICULUM VITAE
PAGE 12
STEVEN E. FELDON, MD
61. Prendiville P, Chopra M, Gauderman WJ, and Feldon SE: The Role of Restricted Motility in
Determining Outcomes for Vertical Strabismus Surgery in Graves’ Ophthlamopathy.
Ophthalmol, 107:545-549, 2000.
62. Chou PI, Chen CH, Chen JT, Wen LY, Wu DA, Feldon SE: Alstrom syndrome with
subclinical insulin-resistant diabetes and hepatic dysfunction: a family report. J Pediatr
Ophthalmol Strabismus, 37:179-82, 2000.
63. Year Retrospective Study. Ophthalmol, 108:1145-1149, 2001.
64. Bhagat N. Green RL, Feldon SE, Lim JI: Exudative Retinal Detachment in Relapsing
Polychondritis: case report and literature review. Ophthalmol, 108:1156-9, 2001.
65. Lee AG, Tang RA, Feldon SE, Pless M, Schiffman JS, Rubin RM, Rao N: Orbital
Presentations of Giant Cell Arteritis: Graefes Arch Clin Exp Ophthalmol, 239:509-13, 2001
66. Feldon SE: Radiation therapy for Graves’ ophthalmopathy: trick or treat?
Ophthalmol,108:1521-2, 2001.
67. Nguyen VT. Park DJ. Levin L. Feldon SE. Correction of restricted extraocular muscle
motility in surgical management of strabismus in graves’ ophthalmopathy. Ophthalmology.
109(2):384-8, 2002.
68. R.W. Crow, L.B. Levin, L. LaBree, R. Reubin, S.E. Feldon. Sweep visual evoked potential
evaluation of contrast sensitivity in Alzheimer’s dementia. Invest. Ophthalmol Vis Sci, 44:
875-8, 2003.
69. Peter Quiros, Steven E. Feldon. Update on Nonarteritic Anterior Ischemic Optic Neuropathy.
Comprehensive Ophthalmology, 4: 151-158, 2003.
70. J M Kim, L LaBree, L Levin, and S E Feldon. The relation of Graves’ ophthalmopathy to
circulating thyroid hormone status. Br. J. Ophthalmol., Jan 2004; 88: 72 - 74.
71. Schmitt N, Grover D, Feldon SE. The Eger Macular Stressometer: Pilot Study. Am J.
Ophthalmol, 2003.
72. Koumas L., Smith TJ., Feldon S., Blumberg N., Phipps RP. Thy-1 expression in human
Fibroblast subsets defines myofibroblastic or lipofibroblastic phenotypes. American Journal
of Pathology, 163 (4): 1291-300, 2003 Oct.
73. Kim JM. LaBree L. Levin L. Feldon SE. The relation of Graves’ ophthalmopathy to
circulating thyroid hormone status. British Journal of Ophthalmology. 88:72-4, 2004 Jan.
74. Feldon, SE. Computerized expert system for evaluation of automated visual fields from the
ischemic optic neuropathy decompression trial: methods, baseline fields, and six-month
longitudinal follow-up. Trans Am Ophthalmol Soc, 102: 269-303, 2004.
Collaborative Publications
75. Ischemic Optic Neuropathy Decompression Trial Study Group. Optic nerve decompression
surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may
be harmful: Results of the Ischemic Optic Neuropathy Decompression Trial. JAMA,
273:625-632, 1995.
76. Ischemic Optic Neuropathy Decompression Trial Study Group. Characteristics of atients
with nonarteritic anterior ischemic neuropathy eligible for the Ischemic Optic Neuropathy
Decompression Trial. Arch Ophthalmol, 114:1366-1374, 1996.
77. Crawley B, Scherer RW, Langenberg P, Dickerson K and the Ischemic Optic Neuropathy
Decompression Trial Study Group. Participation in the Ischemic Optic Neuropathy
Decompression Trial: Sex, race, and age. Ophthalmic Epidemiology, 4:157-173, 1997.
CURRICULUM VITAE
PAGE 13
78.
79.
80.
81.
82.
83.
84.
85.
86.
STEVEN E. FELDON, MD
Ischemic Optic Neuropathy Decompression Trial Study Group. The Ischemic Optic
Neuropathy Decompression Trial (IONDT): Design and methods. Controlled Clin Trials,
19;276-96, 1998.
Ischemic Optic Neuropathy Decompression Trial Research Group. Ischemic optic
neuropathy decompression trial: twenty-four month update. Arch Ophthalmol 118: 793-798,
2000.
Newman JJ, R Scherer, P Langenberg, S. Kelman, S. Feldon, D Kaufman, K Dickersin for
the Ischemic Optic Neuropathy Decompression Trial Research Group. The fellow eye in
NAION: Report from the Ischemic Optic Neuropathy Decompression Trial. Submitted for
Publication to Am J of Ophthalmology. 134 (3): 317-28, 2002 Sept.
Scherer, RW, Zhu Q, Langenberg P, Feldon S, Kelman S, Dickersin K for the Ischemic
Optic Neuropathy Decompression Trial Research Group. Comparison of information
obtained by operative note abstraction to that recorded on a standardized data collection
form. (Journal Article) Surgery. 133 (3): 324-30, 2003.
S. Feldon, RW Scherer, F. Hooper, S. Kelman, R. Baker, R Granadier, G Kosmorsky, S
Seiff, K. Dickersin for the Ischemic Optic Neuropathy Decompression Trial Research Group.
Surgical quality assurance in the Ischemic Optic Neuropathy Decompression Trial (IONDT).
Controlled Clinical Trials 2003: 24:294-305.
S. Feldon, C. Turner, T. Blieden, T. Smith, D. foster, P. Sime, R. Phipps. A novel ELISpot
Method for adherent cells. Journal of Immunological Methods. 291:63-70, 2004:
C. Baglole, Y. Sireesha, S. Pollock, S. Feldon, P. Sime, T. Smith, R. Phipps. Isolation and
Phenotypic Characterization of Lung Fibroblasts. Methods in Molecular Medicine. 117:115127, 2005.
S. Feldon, DJ Park, CW O’Loughlin, VT Nguyen, S. Landskroner-Eiger, D. Chang, TH
Thatcher, RP Phipps. Autologous T-lymphocytes stimulate proliferation of orbital fibroblasts
derived from patients with Graves’ ophthalmopathy. IOVS. 46:3913-21. 2005.
S. Feldon, C. J. Baglole, D.M. Ray, S. H. Bernstein, T. J. Smith, P.J. Sime, R.P. Phipps.
More Than Structural Cells, Fibroblasts Create and Orchestrate the Tumor Microenvironment.
Immunological Investigations. 35:297-325. 2006.
87. S. Feldon, C. O’Loughlin, D. Ray, S. Landskroer-Eiger, K. Seweryniak, R. Phipps. Activated
Human T Lymphocytes Express Cyclooxygenase-2 and Produce Proadipogenic Prostaglandins
that Drive Human Orbital Fibroblast Differentiation to Adipocytes. The American Journal of
Pathology. 169:1183-1193. 2006.
88. S. Feldon, L. Levin, R. Scherer, A. Arnold, S. M. Chung, L. Johnson, G. Kosmorsky,
S. Newman, J. Katz, P. Langenberg, P.D. Wilson, S. E. Kelman, K. Dickersin. Development
And Validation of a Computerized Expert System for Evaluation of Automated Visual Fields
From the Ischemic Optic Neuropathy Decompression Trial. Biomedical Central
Ophthalmology. 2006.
Articles in Press
.
CURRICULUM VITAE
PAGE 14
STEVEN E. FELDON, MD
Non-peer Review
Abstracts
1.
Feldon SE and Newton C: A stochastic epidemiological simulation for heterogenous
populations. Proceedings at The Seventh Annual Symposium for Biomathematics and
Computer Applications in the Life Sciences. Houston, Texas, 1969.
2.
Pollen DA, Andrews BW, and Feldon SE: Spatial frequency selectivity of periodic complex
cells in the cat's visual cortex. Invest Ophthalmol Vis Sci 16 (Suppl):48, 1977.
3.
Stahl SM, Layzer RB, Aminoff MJ, Townsend JJ, and Feldon SE: Continuous cataplexy in a
patient with a midbrain tumor: The limp man syndrome. Neurol 29:540 - 541, 1981.
4.
Goldman DI, Feldon SE, and Ryan SJ: The correlation of quantitative Octopus perimetry
with Canon wide angle fundus angiography and photography in patients with proliferative
diabetic retinopathy. Invest Ophthalmol Vis Sci 20 (Suppl): 92, 1981.
5.
Feldon SE, Hoyt WF, and Stark L: An oculographic study of myasthenia gravis and Fisher's
syndrome with computer simulations. Invest Ophthalmol Vis Sci 20 (Suppl):190, 1981.
6.
Feldon SE: OCTOPUSTM quantitative perimetry in the evaluation of chiasmal field defects.
Invest Ophthalmol Vis Sci 22 (Suppl):226, 1982.
7.
Leemaster JE, Traustason OI, and Feldon SE: Altitudinal visual field defects in patients
without ischemic optic neuropathy: A quantitative comparative analysis by OCTOPUSTM
perimetry. Invest Ophthalmol Vis Sci 24 (Suppl):58, 1983.
8.
Bell JA, Feldon SE, and Diddie KR: The correlation of quantitative OCTOPUS perimetry
with Canon wide-angle fluorescein angiography in patients with non-proliferative diabetic
retinopathy and branch vein occlusion. Invest Ophthalmol Vis Sci 24 (Suppl):112, 1983.
9.
Egge AC, Feldon SE, and LoBue TD: Quantitative correlation between OCTOPUSTM
perimetry and pituitary volume. Invest Ophthalmol Vis Sci 24 (Suppl):133, 1983.
10.
Traustason OI, Leemaster JE, and Feldon SE: A quantitative analysis of visual field loss in
idiopathic ischemic optic neuropathy using OCTOPUSTM automated perimetry. Invest
Ophthalmol Vis Sci 24 (Suppl): 134, 1983.
11.
Feldon SE and Luttrull JK: Diabetic papillopathy of adulthood--a new entity? Invest
Ophthalmol Vis Sci 26 (Suppl): 27, 1985.
12.
Luttrull JK and Feldon SE: Transantral orbital decompression for Graves' ophthalmopathy.
Invest Ophthalmol Vis Sci 26 (Suppl): 220, 1985.
13.
Muramatsu SK and Feldon SE: Infrared oculography of third nerve palsies. Invest
Ophthalmol Vis Sci 26 (Suppl): 258, 1985.
14.
Feldon SE, Thirkill CE, Roth AM, Tyler NK, Keltner JL: Antibody reactions with retroorbital muscle antigens in Graves' ophthalmopathy: evidence of autoimmune hypersensitivity.
Invest Ophthalmol Vis Sci 31 (Suppl): 66, 1990.
15.
Rismondo V, Gierow JP, Lambert RW, Golchini K, Feldon SE, and Mircheff AK: Functional
and ultrastructural characteristics of rabbit lacrimal acinar cells in primary culture. Invest
Ophthalmol Vis Sci 32:1077, 1991.
16.
Feldon SE, Sadun AA, DuBois LG, Yugar JE, and Green RL: Echographic features pre- and
post-optic nerve sheath fenestration for progressive AION. Invest Ophthalmol Vis Sci 32:951,
1991.
17.
Akashi RA, Hofman FM, Leslie ML, Rismondo V, Mircheff AK, and Feldon SE:
Immunopathology of the lacrimal gland in Graves' Ophthalmopathy. Invest Ophthalmol Vis
Sci 32:1112, 1991.
CURRICULUM VITAE
PAGE 15
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29
30.
31.
32.
33.
34.
STEVEN E. FELDON, MD
Feldon SE, Levin L, Gauderman WJ, and Barlow W: Psychological, Social, and Economic
Consequences of Graves' Ophthalmopathy. Pacific Coast Oto-Ophthalmol Soc, 1991.
Feldon SE, Miller MP, Hudson HL, Zimmerman KM, and Silverman SE: Magnocellular
Pathway Degeneration in Alzheimer's Disease: An Oculographic Study of Motion Detection.
Invest Ophthalmol Vis Sci 33:1221, 1992.
Miller MP, Hudson HL, Zimmerman KM, and Feldon SE: Cognitive Visual Dysfunction in
Alzheimer's Disease: An Oculographic Study of Reading and Symbol Rotation Tasks. Invest
Ophthalmol Vis Sci 33:1222, 1992.
Zimmerman KM, Saber E, McDonnell J, Yugar JE, and Feldon SE: Orbital Venous Ligation
Produces Histopathologic Changes in Eye Muscle Similar to Advanced Graves'
Ophthalmopathy. Invest Ophthalmol Vis Sci 33:829, 1993.
Tran DB, Silverman SE, Sadun AA, Zimmerman KM, and Feldon SE: Objective Motion
Detection is not Age-related. Invest Ophthalmol Vis Sci 33:1030, 1993.
Monshizadeh R, Zimmerman KM, and Feldon SE: Orbital Venous Ligation Produces Muscle
Restriction Similar to Advanced Graves' Ophthalmopathy. Invest Ophthalmol Vis Sci 33:
1120, 1993.
Silverman SE, Tran DB, Sadun AA, Zimmerman KM, and Feldon SE: Dissociation Between
the Detection and Perception of Motion in Alzheimer's Disease. Invest Ophthalmol Vis Sci
33:1215, 1993.
Scherer RW, Crawley B, for the Ischemic Optic Neuropathy Study Group. Responses to
ethical and other questions on a knowledge assessment form for a multicenter trial.
Controlled Clin Trials 14:442S. 1993.
Ariyasu RG, Lee M, Zimmerman KM, and Feldon SE: The Potential Use of Mannitol in
Treating Optic Nerve Disease. Invest Ophthalmol Vis Sci 33:1427, 1993.
Hooper F, Urban J, Feldon S, Kelman S, Baker R, Kosmorsky G, Grenadier R, Seiff S and the
Ischemic Optic Neuropathy Decompression Trial (IONDT). Activities of a surgical quality
assurance committee in a multicenter randomized trial. Controlled Clin Trials 15:132S, 1994.
Crawley B, Scherer RW and the Ischemic Optic Neuropathy Decompression Trial (IONDT).
Participation in the IONDT: Race, gender and age. Controlled Clin Trials 15:102S, 1994.
Crawldy B, Waring MT, Scherer RW and the Coordinating Center for the Ischemic Optic
Neuropathy Decompression Trial (IONDT). IONDT Tracking System: Where is form 2034
for patient ICMORE and who is responsible? Controlled Clin Trials 15:93S, 1994.
Huang ZM, Azzarolo AM, Mircheff AK, Esrail R, Grayson G, Heller K, Zimmerman KM,
Feldon SE and Warren DW. Does Estrogen directly affect lacrimal gland function? Invest
Ophthalmol Vis Sci 36:S651, 1995.
Dickerson K and the IONDT Study Group. The natural history of nonarteritic ischemic optic
neuropathy (NAION): Results of the Ischemic Optic Neuropathy Decompression Trial
(IONDT). Invest Ophthalmol Vis Sci 36:S1056, 1995.
Kaufman D and the IONDT Study Group. Optic nerve decompression surgery for
nonarteritic ischemic optic neuropathy (NAION) is not effective and may be harmful: Results
of the Ischemic Optic Neuropathy Decompression Trial (IONDT). Invest Ophthalmol Vis Sci
36:S196, 1995.
Perlmutter D, Scherer R, for the Surgical Treatments Outcomes Project for Dysfunctional
Uterine Bleeding (STOP-DUB) Lurye O, Howard L, for the Ischemic Optic Neuropathy
Decompression Trial (IONDT). Controlled Clin Trials 19:99S-100S, 1998. Presented at the
Nineteenth annual meeting of the Society for Clinicl Trials, Atlanta, GA; May 19, 1998.
Scherer R, Zhu Q, Feldon S, Dickersin K for the IONDT. Comparison of information
CURRICULUM VITAE
PAGE 16
35.
36.
37.
38.
STEVEN E. FELDON, MD
obtained by operative note abstraction to that recorded on a standardized data collection
form. Controlled Clin Trials 21: 108S, 2000. Presented at the twenty-first annual meeting of
the Society for Clinical Trials, Toronto, Cananda; April 18, 2000.
Scherer R, Feldon S. Dickersin K for the IONDT Surgical Quality Assurance Committee.
Assessment of methods used for surgical quality assurance. Controlled Clin Trials 22:48S,
2001. Presented at the twenty-second annual meeting of the Society for Clinical Trials,
Denver, CO; May 22, 2001.
M. R. Agarwal, S.E. Feldon, V. Nguyen. Clinical Features of Graves’ Ophthalmopathy in a
Latino Incidence Cohort. Presented at ARVO 2002.
D. J. Park, D. Chang, V. Nguyen, K. Chamie, R.P. Phipps, S.E. Feldon. Dependent Induction
Of Cell Proliferation in Orbital Fibroblasts of Graves’ Patients During Co-culture with
Autologous T-cells. Presented at ARVO 2002.
The Eger Macular stressometer: Pilot Study. N. Schmitt, D., Grover, S.E. Feldon. Presented
at ARVO 2003.
CURRICULUM VITAE
PAGE 17
STEVEN E. FELDON, MD
Book Reviews
1.
Feldon SE: The Eye and Orbit in Thyroid Disease. Gorman CA, Waller RR, and Dyer, JA
(eds.). New York: Raven Press, 1984. In: Am J Ophthalmol, 1985.
2.
Feldon, SE: The Diagnosis and Management of Orbital Tumors. Laws ER (ed.). In: N Eng
J Med 321/12:841, 1989.
3.
Feldon, SE: Developments of Ophthalmology. Vol. 20. Pickardt R, Boergen KP, Karger,
Basel (eds.). In: Am J Ophthalmol 109/3:365 - 366, 1990.
Letters to the Editor
1.
Friedman DI and Feldon SE: Eye movement abnormalities in the Acquired
Immunodeficiency Syndrome (Letter to the Editor). Arch Neurol 46:841, 1989.
2.
Sadun AA, Heller KB, and Feldon SE: Model for optic nerve sheath decompression:
Bernoulli's principle applied. Letter to the Editor. Arch Ophthalmol 109:612, 1991.
3.
Hudson HL, Levin LB, and Feldon SE: Graves' Exophthalmos without Muscle Involvement.
Letter to the Editor. Ophthalmol 99:645, 1992.
4.
Aiello AL, Sadun AA, Feldon SE: Spontaneous Improvement of Progressive AION: A
Report of Two Cases. Letter to the Editor. (Response to Kwitko). Arch Ophthalmol.
111:300, 1993.
5.
Feldon SE: Classification of Graves' eye changes. Letter to the Editor. Thyroid. 3(2):171,
1993.
6.
Feldon SE: Management of Graves' Ophthalmopathy with optic nerve involvement. Letter to
the Editor. Mayo Clin Proc. 68(6):616- - 617, 1993.
7.
Aiello AL, Sadun AA, Feldon SE. Spontaneous Improvement of Progressive AION: A
Report of Two Cases. Letter to the Editor. (Response to McHenry and Spoor). Arch
Ophthalmol. 111(12):1602-1603, 1993.
8.
Feldon SE: Anterior Ischemic Optic Neuropathy: Trouble Waiting to Happen. Guest
Editorial. Ophthalmol. 106(4):651-652, 1999.
9.
Feldon SE: Response to Anterior Ischemic Optic Neuropathy: Trouble Waiting to Happen.
Ophthalmol. 106:2235, 1999.
10. Feldon SE: Response to Anterior Ischemic Optic Neuropathy: Trouble Waiting to Happen.
Ophthalmol. 107:409, 2000.
11. Feldon SE: Response to The Role of Restricted Motility in Determining Outcomes for
Vertical Strabismus Surgery in Graves’ Ophthalmopathy. Ophthalmol, 108:243, 2001.
Monographs and Chapters
1.
Feldon SE, Stark L, Lehman SL, and Hoyt WF: Saccadic abnormalities in diseases of the
peripheral nervous system. In: Functional Basis of Ocular Motility Disorders. Lennerstrand
G, Zee DS, and Keller EL (eds.). Oxford: Pergamon Press, 1982, pp 545 - 548.
2.
Feldon SE: Management of thyroid-eye disease. In: Focal Points: Clinical modules for
ophthalmologists, Member Benefit Module 2. American Academy of Ophthalmology, San
Francisco, 1984.
3.
Feldon SE: Ocular motor system. In: 1984 - 1985 Ophthalmology Basic and Clinical
Science Course, Section 5, Neuro-Ophthalmology, Chapter 3. American Academy of
Ophthalmology, Atlanta, 1984.
4.
Feldon SE: Computerized perimetry in selected disorders of the retina. In: Computerized
Visual Fields: What They Are and How to Use Them. Whalen WR, and Spaeth GL (eds.).
Thorofare, New Jersey: Slack, 1985, pp 277 - 296.
CURRICULUM VITAE
PAGE 18
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
STEVEN E. FELDON, MD
Feldon SE and Wallace DA: A new generation of diagnostic ultrasonic instrumentation: The
Bio-Pen biometric ruler and the Pach-Pen pachymeter. In: Acta XXV Concilium
Ophthalmologicum - Blodi F, Brancato R, Cristini G, d'Ermo F, Esente I, Musini A, Philipson
B, Pintucci F, Ponte F, and Scuderi G (eds.). Kugler and Ghedeni: Berkeley, California,
1987, pp 602 - 608.
Feldon SE, Burde RM, and Walonker AF: The extraocular muscles. In: Adler's Physiology
of the Eye: Clinical Application, (8th edition). Moses RA, and Hart WM, Jr. (eds.). St.
Louis: CV Mosby, 1987, pp 89 - 182.
Feldon SE and Wallace DA: The Tono-Pen tonometer: Description and performance. In:
Acta XXV Concilium Ophthalmologicum. Blodi F, Brancato R, Cristini G, d'Ermo F, Esente I,
Musini A, Philipson B, Pintucci F, Ponte F, Scuderi G (eds.). Kugler and Ghedini, Berkeley,
California, 1987, pp 597 - 601.
Feldon SE (contributing editor): Focal Points 1988: Clinical Modules for Ophthalmologists,
Vol. 8, Module 8 Headache. American Academy of Ophthalmology, San Francisco, 1988.
Feldon SE: Visual fields in retinal disease. In: Retina. Vol. I: Basic Science and Inherited
Retinal Disease. Ryan SJ and Ogden TE (eds.). St. Louis: CV Mosby, 1989, pp 133 - 150.
Feldon SE: Diagnostic Tests and Clinical Techniques in the Evaluation of Graves'
Ophthalmopathy. In: Pathogenesis and Management of Graves' Ophthalmopathy. Wall JR
and How J (eds.). Boston: Blackwell Scientific Publications, 1990, pp 79 - 93.
Feldon SE: Tumors of the Anterior Visual Pathway. In: Principles and Practice of
Ophthalmology. Jakobiec F and Albert D (eds.). Philadelphia: WB Saunders Company,
1994, Vol. 4, pp 2578-2592.
Feldon SE: Visual fields in retinal disease. In: Retina. 3rd Edition. Basic Science and
Inherited Retinal Disease. Ryan SJ and Ogden TE (eds.). St. Louis: CV Mosby. 1999.
Feldon SE: Future Research in Graves’ ophthalmopathy. In: Recent developments in
Graves’ ophthalmopathy. Drexhage HA, Weetman AP, Heufelder AE, Feldon SE, Koornneef
L, Mourits MP, Wiersinga WM, Prummel MF. Boston: Kluwer Academic Publishers, 2000,
pp 171 – 194.
Feldon SE, Baglole CA, Smith TE, Foster DA, Sime PA, Phipps RI: Functional Assessment
of Fibroblast Heterogeneity by the Cell-Surface Glycoprotein Thy-1. In: Tissue Repair,
Contraction and the Myofibroblast. Chaponnier C, Desmouliere A, Gabbiani G (eds.)
Eurekah.com and Springer Science+Business Media, 2006. pp32-39.
Chapters in Progress
H. PATENTS
1.
Feldon SE, Broome BG, and Wallace DA. An improved keratometer. Patent Number
4,597,648. Issued July 1, 1986.
2.
Feldon SE, Wallace DA, Mezak G, and Monsour A. Electronic tonometer with base-line
nulling system. 4,747,296. Issued May 31, 1988.
3.
Feldon SE, Wallace DA, Grove JE, and Halseth TR. Ophthalmic Instrument. Patent Number
D298,856. Issued December 6, 1988.
4.
Wallace DA, Feldon SE, Mezak G, Whiting DL, Dally WJ, Karns SA. Digital Ultrasonic
Instrument for Ophthalmic Use. Patent Number 4,817,432. Issued April 4, 1989.
5.
Wallace DA and Feldon SE. Self-contained hand-held ultrasonic instrument for Ophthalmic
use. Patent Number 5,165,415. Issued November 24, 1992.
CURRICULUM VITAE
PAGE 19
6.
7.
STEVEN E. FELDON, MD
Feldon SE and Agrawal JP. Electronic documentation system for generating written reports.
Patent Number 5,732,221. Issued March 3, 1998.
Feldon SE, Burr BA, Teasdale RW, Netherwood GJ. Applanation tonometer. United States
Patent number 6,776,756. Issued August 17, 2004.
CURRICULUM VITAE
PAGE 20
8.
9.
I.
STEVEN E. FELDON, MD
Feldon SE, Burr BA, Teasdale, RW, Netherwood GJ. Disposable tip for tonometer. Patent
Pending.
Feldon SE, Yoon G. Compact Ocular Fundus Camera. Patent Pending.
SCIENTIFIC MEETINGS AND PRESENTATIONS
NAMED LECTURES
1. Gifford Lecture. Thyroid-related Eye Disease: what is it and how is it treated? Chicago
Ophthalmological Society 55th Annual Clinical Conference. Wilmette, IL April, 2003.
2. Estelle Doheny Lecture. Thyroid-related Eye Disease: what is it and how is it treated? Annual
Doheny Days Conference. June 13-14, 2003. Doheny Eye Institute, Los Angeles, California.
3. Rich Lecture. An in vitro model for the study of Graves’ ophthalmopathy. University of
Alabama. Birmingham, AL. January 2004.
4. David Worthen Memorial Lecture. An vitro Model for the Study of Graves’ Ophthalmopathy.
The Wilmer Eye Institute, Baltimore, MD. March 2004.
5. Illinois Society for the Prevention of Blindness Lecture. Non-Arteritic Ischemic Optic
Neuropathy (NAION): What’s New? Chicago
Ophthalmological Society IAO/COS 2006 Joint Conference. Vernon Hills, IL. February 2006.
PRESENTATIONS
1979
1.
CT Scanning in Neuro-Ophthalmic Diseases. Tricounty Ophthalmologic Association Orange County Ophthalmology Association. April 24, 1979. Santa Ana, California.
2.
The Role of the Vitreous in Diseases of the Optic Nerve Head. Annual Doheny Meeting.
September 12, 1979. Los Angeles, California.
3.
Dysthyroid Ophthalmopathy - An Introduction; Solid and Vascular Lesions of the Cavernous
Sinus. Estelle Doheny Orbit Conference. November, 1979. Los Angeles, California.
1980
1.
2.
3.
4.
5.
6.
Internuclear Ophthalmoplegia. Guest Lecturer - Rancho Los Amigos Hospital. February 20,
1980. Downey, California.
Acquired Trans-synaptic Hemioptic Atrophy: Two Cases. Internuclear Ophthalmoplegia of
Abduction: Analysis of Eye Movement. Recordings with Computer Simulations. The Third
International Neuro-Ophthalmology Meeting. March 19, 1980. Valbella, Switzerland.
CT Scanning in Neuro-ophthalmology. Guest Lecturer - Loma Linda Department of
Ophthalmology. March 26, 1980. Loma Linda, California.
Internuclear and Nuclear Control Mechanisms and their Disorders. Mechanisms of Eye
Movement Abnormalities in Myasthenia Gravis. Guillain-Barré Syndrome. Eye Movement
Symposium. April 14, 1980. Portland, Oregon.
New Techniques in Neuro-Ophthalmology. Midway Hospital. May 20, 1980. Los Angeles,
California.
OCTOPUS Computerized Perimetry. Yale Alumni Association. June 6, 1980. Boston,
Massachusetts.
CURRICULUM VITAE
PAGE 21
7.
8.
1981
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
STEVEN E. FELDON, MD
Differential Diagnosis. Medical and Surgical Management of Orbital Tumors. The Fixed
Dilated Pupil. Third and Sixth Nerve Palsies. Monocular Nystagmus in Children and Adults.
Mechanisms in Internuclear Ophthalmoplegia. Papilledema in Increased Intracranial Pressure.
Horner's Syndrome. Infiltrative and Compressive Neuropathies. Eye Movement Patterns in
Neuro-myopathies. New Visual Field Technology Automated Perimetry. Clinical Problems
in Pediatric and Neuro-Ophthalmology. University of Southern California School of
Medicine Postgraduate Division and the Department of Ophthalmology. June 14-21, 1980.
Kamuela, Hawaii.
Optic Neuritis, Inflammation, Demyelination, and Ischemia: Diagnosis and Therapy. Annual
Doheny Meeting. October 1-3, 1980. Los Angeles, California.
CT Scanning of the Orbit. Diagnostic Ultrasound Course. January 8, 1981. Los Angeles,
California.
Eye Movements in Myasthenia Gravis. Neurology Basic Science Conference, LAC/USC
Medical Center. January, 1981. Los Angeles, California.
Automated Perimetry. Santa Monica Hospital - Ophthalmology and Grand Rounds. January,
1981. Santa Monica, California.
Evaluation of Dysthyroid Ophthalmopathy by Eye Movement Recordings. Clinical Eye
Movement Seminar. January 21, 1981. Los Angeles, California.
Internuclear Ophthalmoplegia: Oculomotor Symposium at the California Institute of
Technology. January, 1981. Pasadena, California.
Signs and Symptoms of Chiasmal Compression. Southern California Neurological Society
Meeting. February 13, 1981. Beverly Hills, California.
Bitemporal Field Loss, Recurrent Meningitis, and "Empty Sella." Frank Walsh Society
Meeting. February 27-28, 1981. Houston, Texas.
Fascinating Orbital Tumors with CT Correlation. Santa Ana Community Hospital. April 17,
1981. Santa Ana, California.
An Oculographic Study of Myasthenia Gravis and Fisher's Syndrome with Computer
Simulation. Association for Research in Vision and Ophthalmology Meeting. April 27-May
1, 1981. Sarasota, Florida.
Automated Perimetry in Retinal and Neurological Diseases. New York Eye and Ear Infirmary
Alumni Meeting. May 8, 1981. New York, New York.
Neuro-Ophthalmology: Value of Steroids in Optic Neuritis - Round Table Discussion. Pan
American Congress on Ophthalmology. May 10-15, 1981. Acapulco, Mexico.
Automated Perimetry in Retinal and Neurological Disease. Massachusetts Eye and Ear
Infirmary Alumni Meeting. May 18-19, 1981. Boston, Massachusetts.
Eye Movements in Graves' Dysthyroid Ophthalmopathy. Fourth International Symposium of
Orbital Disorders. August 31 - September 2, 1981. Amsterdam, The Netherlands.
Disorders of Cerebral Control of Eye Movements. Functional Basis of Ocular Motility
Disorders Symposium. August 31 - September 3, 1981. Stockholm, Sweden.
Quantitative Volumetric CT Scanning in Graves' Ophthalmopathy. Rounds at St. Thomas'
Hospital. September 17, 1981. London, England.
Low Tension Glaucoma. Thirteenth Annual Doheny Meeting. September 23 - 25, 1981. Los
Angeles, California.
Hysteria and Malingering. Medical Malpractice in Ophthalmology Course - Memorial
Hospital Medical Center of Long Beach. October 2, 1981. Long Beach, California.
CURRICULUM VITAE
PAGE 22
18.
19.
1982
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
1983
1.
2.
3.
4.
5.
6.
7.
STEVEN E. FELDON, MD
Neurological Surgery: What You Don't Know Might Hurt (Based on an analysis of SESAP III
- SANS data). Neurological Surgery Panel Discussion. Sixty-seventh Clinical Congress of
the American College of Surgeons. October 11 - 16, 1981. San Francisco, California.
The Optic Neuropathies. Centinela Hospital Medical Center. December 21, 1981.
Inglewood, California.
Papilledema. Huntington Memorial Hospital - Neuro-surgery Conference. January 4, 1982.
Pasadena, California.
CT Scanning of the Orbit. Saint Joseph Medical Center. January 20, 1982. Burbank,
California.
CT Evaluation. Eye Movements. CT Anatomy of Brain and Orbit for the Ophthalmologist.
Orbital Conference. Director - LAC/USC Department of Ophthalmology. April 2 -3, 1982.
Los Angeles, California.
OCTOPUS Quantitative Perimetry in the Evaluation of Chiasmal Field Defects. Association
for Research in Vision and Ophthalmology. May 3 - 7, 1982. Sarasota, Florida.
CT Scanning of Orbits. Guest Lecturer - Scripps Memorial Hospital. May 27, 1982. La
Jolla, California.
Eye Movement Recordings in Progressive External Ophthalmoplegia. Fourth International
Congress on Neuro-Ophthalmology. June 12 - 17, 1982. Bermuda.
Optic Nerve and Orbital Trauma. Fourteenth Annual Doheny Meeting. September 9 - 11,
1982. Los Angeles, California.
Radiology of the Orbit. LAC/USC Department of Radiology. September 20, 1982. Los
Angeles, California.
Office Management of Thyroid Disease. American Academy of Ophthalmology. November
1 - 6, 1982. San Francisco, California.
Computers in Ophthalmology. ARCS Foundation. November 1, 1982. San Francisco,
California.
Neuro-ophthalmology. Rancho Los Amigos, Department of Ophthalmology and Grand
Rounds. November 17, 1982. Downey, California.
Optic Nerve Complications Following Cataract Extraction and Other Intraocular Surgeries.
Annual Palm Springs Weekend. December 3 - 4, 1982. Palm Springs, California.
Computers in Ophthalmology. Research Study Club Mid-Winter Conference. January 23 26, 1983. Los Angeles, California.
Surgery of the Orbit. University of California, Irvine, Basic Science Course, Department of
Ophthalmology. February 2, 1983. Irvine, California.
Analysis of Saccades in Graves' Ophthalmopathy. Frank Walsh Society Meeting. February 24
- 26, 1983. New Orleans, Louisiana.
Clinical Pathologic Correlations in the Orbit. Diagnostic Ophthalmic Ultrasound Course.
March 3 - 5, 1983. Los Angeles, California.
Myopathic Eye Movements. Neuroscience Seminar. April 14, 1983. Los Angeles, California.
Neuro-ophthalmology. LAC/USC Year III Ophthalmology Elective Lecture Series. April 29,
1983. Los Angeles, California.
Moderator. Seventh Annual Doheny Residents', Fellows', and Alumni Day Meeting. June 10,
1983. Los Angeles, California.
CURRICULUM VITAE
PAGE 23
8.
9.
10.
11.
12.
1984
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
STEVEN E. FELDON, MD
Migraine. Vascular Syndromes in the Optic Nerve. Manual and Automated Perimetry. The
Arcuate Areas in Glaucoma and Optic Nerve Disease. Colobomas and Congenital Anomalies.
Case Presentations. Visual Fields in Papilledema. Optic Nerve Decompression. Orbital
Anatomy and CT Scanning. Orbital Tumors - Clinical Pathologic Correlations. Optic Nerve
Meningiomas. Ischemic Optic Neuropathy. Clinical Problems in Glaucoma, Optic Nerve and
Orbital Disease. University of Southern California School of Medicine Postgraduate Division
and the Department of Ophthalmology. June 18 - 25, 1983. Kamuela, Hawaii.
Quantitative Analysis of Octopus Visual Fields. Octopus Users' Society.
August 12 - 13, 1983. Niagara Falls, New York.
Laser in Orbital Diseases and Neuro-ophthalmology. Annual Doheny Meeting. September 15
- 16, 1983. Industry Hills, California.
Basic Neuro-ophthalmology, Parts I [Case Histories. Parachiasmal Disease and Tract], II
[Nystagmus and Nystagmoid Movements. Orbital and Cavernous Sinus Disease (Moderator).
Thyroid Ophthalmopathy and Pseudotumor], and III [CT Scan and Correlation]. American
Academy of Ophthalmology. October 30 - November 4, 1983. Chicago, Illinois.
Graves' Ophthalmopathy. Annual Palm Springs Weekend. December 8 - 9, 1983. Palm
Springs, California.
Ultrasonography in Thyroid. Rocky Mountain Neuro-Ophthalmology Society. January 15 22, 1984. Snowbird, Utah.
Neuro-Ophthalmology Selected Clinical Problems. Research Study Club Mid-Winter
Conference. January 24, 1984. Los Angeles Hilton, Los Angeles, California.
Myopathy of Graves' Disease. Hollywood Community Hospital. March 9, 1984. Los
Angeles, California.
Statistical Analysis of OCTOPUS Visual Fields. Octopus Users' Society Meeting. Moderator
- Data Transmission Panel. March 14 - 17, 1984. Denver, Colorado.
Proptosis: Differential Diagnosis, Evaluation, and Management. Guest Lecturer - University
of California, Irvine. March 21, 1984. Irvine, California.
Risk Factors Contributing to Optic Neuropathy in Graves' Ophthalmopathy. Joint World
Meeting of Neuro-Ophthalmology. May 13 - 18, 1984. Antwerp, Belgium.
Graves' Ophthalmopathy. LAC/USC Department of Endocrinology Grand Rounds. June 5,
1984. Los Angeles, California.
Graves' Ophthalmopathy. Huntington Memorial Hospital Grand Rounds.
August 2, 1984. Pasadena, California.
Head and Neck Radiology. LAC/USC Department of Radiology.
September 8 - 9, 1984. Los Angeles, California.
Annual Doheny Meeting. Estelle Doheny Eye Foundation. September 12 - 14, 1984. Los
Angeles, California.
Case Histories. Parachiasmal Disease. American Academy of Ophthalmology. November
11-15, 1984. Atlanta, Georgia.
Annual Palm Springs Weekend. December 6 - 8, 1984. Palm Springs, California.
All Day Clinical Conference. Estelle Doheny Eye Foundation. December 14, 1984. Los
Angeles, California.
CURRICULUM VITAE
PAGE 24
1985
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
1986
1.
2.
3.
4.
STEVEN E. FELDON, MD
Discussion of the Orbit and Extraocular Muscles. Physician Assistant Program. University of
Southern California School of Medicine. January 8, 1985. Los Angeles, California.
Orbital Tumor. Basic Science Course - Uveitis and Ocular Tumors. University of California,
Irvine, Department of Ophthalmology. January 16, 1985. Irvine, California.
Diagnostic Filing System for Octopus Records Stored on the IBM PC. Fourth Annual
Octopus Users' Society Meeting. Panel Member - Service Forum. Moderator - Business
Section. February 8 - 9, 1985. San Diego, California.
Post-Ganglionic Horner's Syndrome in a Young Woman. Seventeenth Annual Frank B.
Walsh Society Meeting. February 22 - 23, 1985. Baltimore, Maryland.
Visual Fields in Anterior Ischemic Optic Neuropathy: A Quantitative Assessment Using
Octopus Perimetry. Quantitative Analysis of Ischemic Optic Neuropathy. Post-Ganglionic
Horner's Syndrome in a Young Woman. Rocky Mountain Neuro-Ophthalmological Society
Meeting. Moderator - Optic Nerve Session. March 2 - 10, 1985. Banff, Alberta, Canada.
Eye Movements in Graves' Disease. 1985 Western Regional Orthoptic Meeting. March 21 22, 1985. Los Angeles, California.
Diabetic Papillopathy of Adulthood -- A New Entity? Transantral Orbital Decompression for
Graves' Ophthalmopathy. Infrared Oculography of Third Nerve Palsies. Association for
Research in Vision and Ophthalmology. May 6 - 10, 1985. Sarasota, Florida.
CAT Scan - Orbital Disease and Thyroid Ophthalmopathy. Moderator - Glaucoma Panel.
Estelle Doheny Eye Hospital Scientific Dedication Meeting. June 5 - 7, 1985. Los Angeles,
California.
Several Innovations in Ophthalmic Diagnostic Instrumentation. USC/Doheny Residents' Alumni Day. June 21, 1985. Los Angeles, California.
Duane's Syndrome and Internuclear Ophthalmoplegia. Neuroscience Grand Rounds. VA
Medical Center. July 26, 1985. La Jolla, California.
Graves' Ophthalmopathy. Endocrine Grand Rounds. LAC/USC Medical Center. October 15,
1985. Los Angeles, California.
Computers in Ophthalmology. Orange County Retina Medical Group. October 18 - 19, 1985.
Palm Springs, California.
Diagnosis and Management of Graves' Ophthalmopathy. Grand Rounds. Loma Linda
University School of Medicine. Chiasmal Syndromes. Southern California Eye Society.
October 23, 1985. Los Angeles, California.
Diabetic Papillopathy of Adulthood -- A New Entity? 17th Annual Doheny Meeting. Estelle
Doheny Eye Foundation. December 12-14, 1985. Los Angeles, California.
Pituitary Carcinoma, Will Travel. 18th Annual Frank Walsh Society Meeting. February 2122, 1986. Seattle, Washington.
Visual Loss in Pituitary Tumors. 12th Annual Rocky Mountain Neuro-Ophthalmology
Society Meeting. February 23-27, 1986. Whistler, British Columbia, Canada.
Automated Perimetry in Neuro-ophthalmology. Chiasmal Syndromes. American Academy of
Ophthalmology Western Regional Update Course. March 7-9, 1986. Seattle, Washington.
Management of Orbital Tumors. Neurosurgery Conference. April 15-16, 1986. Denver,
Colorado.
CURRICULUM VITAE
PAGE 25
5.
6.
7.
8.
9.
10.
1987
1.
2.
3.
4.
5.
1988
1.
2.
3.
STEVEN E. FELDON, MD
Differential Diagnosis and Management of Orbital Tumors. Ocular Tumors and Inflammation
Course. Estelle Doheny Eye Medical Clinic, Inc. February 14, 1986. Los Angeles,
California.
Correlation of Pituitary Tumor Size with Quantitative Octopus Perimetry. USC
Residents'/Alumni Day. June 13, 1986. Los Angeles, California.
Types and Tempos of Optic Neuropathies. Optic Pits and Other Non-Glaucomatous Disc
Cupping. Optic Nerve Decompression. Orbital Imaging - CT. Papilledema in CNS Disease.
Headache - Migraine. Thyroid and Orbit Disease. The Fixed Dilated Pupil. Differential
Diagnosis Unequal Pupil. Diplopia. Glaucoma, Neuro-ophthalmology and Pediatric
Ophthalmology. June 21-28, 1986. Kamuela, Hawaii.
Selection of Imaging Techniques in Diagnosis of Orbital and Neurological Problems (NMR,
PET, CAT Scan). Eighteenth Annual Estelle Doheny Eye Foundation Meeting. September
11 - 12, 1986. Los Angeles, California.
Anomalous Discs. Dysthyroid Ophthalmopathy and Other Orbital Disorders. Migraine
Headache. Nystagmus and Related Ocular Motor Disorders. Parachiasmal and Optic Tract
Disease. Basic Neuro-ophthalmology, Course No. 427. Moderator - Ischemic Optic
Neuropathy. American Academy of Ophthalmology. November 9-14, 1986. New Orleans,
Louisiana.
Graves' Ophthalmopathy. Rancho Los Amigos Medical Center Endocrinology Journal Club.
December 16, 1986, Downey, California.
Ultrasound of Orbital Tumors. USC/Doheny Ultrasound Course. January 22-24, 1987. Los
Angeles, California.
Biochemistry of Migraine. 13th Annual North American Neuro-ophthalmological Meeting.
February 1 - 5, 1987. Lake Tahoe, California.
Graves' Ophthalmopathy: Medical and Surgical Management. Annual Jules Stein
Postgraduate Seminar. April 10, 1987. Los Angeles, California.
The Management of Orbital Tumors. USC/Doheny Ocular Tumors Course.
May 15, 1987. Los Angeles, California.
The Anomalous Disc. Posterior Afferent System (Moderator): Case Histories. Migraine
Headache. Double Vision (Moderator): Orbital Causes of Diplopia. American Academy of
Ophthalmology, November 8 - 12, 1987. Dallas, Texas.
Intraocular Vascular Complications of Orbital Masses. North American Neuroophthalmologic Society. February 21 - 25, 1988. Crested Butte, Colorado.
Penetrating Injuries Affecting Extraocular Muscles. Penetrating Injuries Affecting Optic
Nerves. MRI Scanning of the Orbit. Invited guest lecturer. Swedish Ophthalmological
Association. May 5 - 6, 1988. Goteborg, Sweden.
Anterior Ischemic Optic Neuropathy: Classification of Field Defects by Octopus Automated
Static Perimetry. Infrared Oculography of Duane's Retraction Syndrome Type I. International
Neuro-Ophthalmology Congress. May 6 - 12, 1988. Vancouver, British Columbia, Canada.
CURRICULUM VITAE
PAGE 26
4.
5.
6.
7.
1989
1.
2.
3.
4.
5.
6.
1990
1.
2.
3.
4.
5.
6.
7.
STEVEN E. FELDON, MD
Clinical Techniques and Diagnostic Tests in the Evaluation of Graves' Ophthalmopathy. The
Role of Extraocular Muscles in the Development and Treatment of Optic Neuropathy. Optic
Disc Anomalies. Penetrating Injuries Affecting Extraocular Muscles. Penetrating Injuries
Affecting Optic Nerves. Visiting Professor. Bethesda Eye Institute. September 16 - 17,
1988. St. Louis, Missouri.
Clinical Techniques and Diagnostic Tests in the Evaluation of Graves' Ophthalmopathy. The
Role of Extraocular Muscles in the Development and Treatment of Optic Neuropathy. First
International Symposium on Graves' Ophthalmopathy. September
27 - 28, 1988. Montreal, Quebec, Canada.
The Anomalous Disc. Posterior Afferent System (Moderator): Case Histories. Migraine
Headache. Double Vision (Moderator): Orbital Causes of Diplopia. American Academy of
Ophthalmology, October 6 - 13, 1988. Las Vegas, Nevada.
Management of "Strabismus" in Thyroid Eye Disease. Twentieth Annual Doheny Meeting.
Doheny Eye Institute. November 17 - 18, 1988. Los Angeles, California.
An Enigma of the Maxillary Nerve. Frank B. Walsh Society. February 9 - 10, 1989.
Philadelphia, Pennsylvania.
Peripheral Inflammatory Processes Affecting Ocular Motor Function: Ocular Myasthenia
Gravis, Miller-Fisher's Syndrome and Thyroid Ophthalmopathy. North American Neuroophthalmology Society. April 6 - 13, 1989. Cancun, Mexico.
Monocular Diplopia. Neuro-ophthalmological Symposium, White Memorial Hospital.
March 18, 1989. Los Angeles, California.
Migraine Headache. Optic Nerve Decompression. Tumors of the Optic Disc and Nerve.
Papilledema in CNS Disease. August 7 - 11, 1989. Mauna Kea, Hawaii.
Current Therapy for Thyroid Eye Disease: Steroids, Radiation, or Surgery? Twenty-First
Annual Doheny Meeting. September, 21 - 22, 1989. Los Angeles, California.
Evaluation and Treatment of Diplopia. Graves' Ophthalmopathy. American Academy of
Ophthalmology. October 29 - November 2, 1989. New Orleans, Louisiana
Management of Orbital Tumors. North American Neuro-Ophthalmology Society. February 4
- 8, 1990. Steamboat Springs, Colorado.
Frank B. Walsh Society 22nd Annual Meeting. Painful Ophthalmoplegia - More Than Meets
the Eye (co-author) February 15 - 17, 1990. Indianapolis, Indiana.
Current Neuro-Imaging (What Scans to Order When). American Academy of Ophthalmology
Western Regional Update Course. Irvine, California. and JCAHPO Continuing Education
Course, Newport Beach, California. February 23 - 25, 1990.
Neurology and Neurosurgery Review Course. Osler Institute. March 6, 1990. San Francisco,
California.
Ophthalmology Review Course. Osler Institute. May 8, 1990. San Francisco, California.
Blepharospasm and Related Disorders. Neuro-Ophthalmology Short Course. Doheny Eye
Referral Center. May 12, 1990. Anaheim, California.
Thyroid Ophthalmopathy. Third North American Course-Pan American Society. May 25,
1990. Orlando, Florida.
CURRICULUM VITAE
PAGE 27
8.
9.
10
11.
12.
13.
1991
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
1992
1.
2.
STEVEN E. FELDON, MD
Use and Abuse of Corticosteroids in Managing Optic Neuropathies; Unusual Presentations of
Orbital Pseudotumor; Headache and (for) the Ophthalmologist; and Medical and Surgical
Management of Graves' Ophthalmopathy. 10th Annual Current Concepts in Ophthalmology
Meeting. June 22 - 24, 1990. La Jolla, California.
Infrared oculography of symbol rotation tasks in the evaluation of cognitive dysfunction - a
study of AIDS-related dementia. International Neuro-ophthalmology Society Meeting. June
25 - 29, 1990 Winchester, England.
Diabetic Cranial Nerve Palsies Affecting Ocular Motility. 22nd Annual Doheny Meeting.
September 27, 1990. Los Angeles, California.
Basic Neuro-ophthalmology Course; Automated Perimetry Course. American Academy of
Ophthalmology. October 26 - November 1, 1990. Atlanta, Georgia.
Ophthalmology Review Course. Osler Institute. Nov 13, 1990. San Francisco, California.
Evaluation of Orbital Tumors. JCAHPO Continuing Education Course. December 1, 1990.
Newport Beach, California.
Neurology and Neurosurgery Review Course. Osler Institute. Jan 10, 1991. San Francisco,
California.
Painful Ophthalmoplegia - Much More Than Meets the Eye. Frank B. Walsh Society 23rd
Annual Meeting. February 22 -23, 1991. Salt Lake City, Utah.
Echographic Features Pre- and Post-Optic Nerve Sheath Fenestration for Progressive AION
(poster). The Association for Research in Vision and Ophthalmology. April 28 - May 3,
1991, Sarasota, Florida.
Outcomes of Motility Surgery in Graves' Ophthalmology. 15th Annual Alumni - Residents
Day. May 31 - June 1, 1991. Doheny Eye Institute, Los Angeles, California.
Evaluation and Sociological Aspects of Graves' Ophthalmology. Pacific Coast OtoOphthalmological Society. June 15 - 19, 1991. Monterey, California.
Medical Management of Graves' Ophthalmopathy: Is there a Place for Immunosuppressive
Therapy? International Symposium on Graves' Disease. August
23 - 24, 1991. Amsterdam, Holland.
Update Course in Ophthalmology; Optic Nerve Sheath Fenestration - Medical Approach.
Pan American Association of Ophthalmology. October 9 -10, 1991. Doheny Eye Institute,
Los Angeles, California.
Basic Neuro-Ophthalmology Course; Automated Perimetry Course. American Academy of
Ophthalmology. October 13 - 17, 1991. Anaheim, California.
Orbital Complications of Non-orbital Surgery. Late Overcorrection of Vertical Deviations
after Muscle Surgery in Graves' Ophthalmopathy. 23rd Annual Doheny Days. December 5 6, 1991. Doheny Eye Institute, Los Angeles, California.
Management of Orbitocranial Lesions. Skull Base Symposium. December 14, 1991.
University of Southern California, Los Angeles, California.
Orbital venous stasis: A new model of Graves' Ophthalmology. North American NeuroOphthalmology Society. February 23 - 27, 1992. Rancho Bernardo, San Diego, California.
24th Annual Frank B. Walsh Society Meeting. February 28 - 29, 1992. Doheny Eye Institute,
Los Angeles, California.
CURRICULUM VITAE
PAGE 28
3.
4.
5.
6.
7.
8.
1993
1.
2.
1994
1.
2.
3.
1995
1.
2.
3.
4.
5.
6.
STEVEN E. FELDON, MD
Outcomes analysis quality assessment and health care regulations. March 27, 1992. Doheny
Eye Institute , Los Angeles, California.
Orbital Update. The International Day of the Centennial of the Netherlandish
Ophthalmological Society. June 19, 1992. Maastricht, The Netherlands.
Optic Nerve Sheath Fenestration: Indications and Techniques. Clinical Approach to Isolated
Cranial Nerve Palsy. Myasthenia Gravis. MRI Scanning of Neuro-Ophthalmic Disease.
Graves' Ophthalmopathy Update. Transantral Orbital Decompression. August 15 - 22, 1992.
Mauna Kea, Hawaii.
Graves' Ophthalmopathy Symposium. American Thyroid Association. September 21 - 24,
1992. Rochester, Minnesota.
American Board of Ophthalmology exams. October 14 - 16, 1992. San Francisco, California.
Basic Neuro-Ophthalmology Course. American Academy of Ophthalmology. November 8 12, 1992. Dallas, Texas.
Ischemic Optic Neuropathy Decompression Trial: Rationale and Design. North American
Neuro-Ophthalmological Society. February 7 - 11, 1993. Big Sky, Montana.
25th Annual Frank B. Walsh Society Meeting. March 11 - 13, 1993. Rockefellar University,
New York, New York.
Graves’ Ophthalmopathy. Visiting Professor, Mayo Clinic. February 9 - 11, 1994.
Rochester, Minnesota.
Ischemic Optic Neuropathy Treatment Trial: An Update. Alumni/Residents Day. Doheny
Eye Institute. June 10 - 11, 1994. Los Angeles, California.
Visiting Professor, Syracuse University. October 3 - 4, 1994. Syracuse, New York.
Optic nerve sheath decompression in NAION. 26th Annual Postgraduate Seminar. Jules
Stein Institute. April 7 - 8, 1995. Los Angeles, California.
The natural history of nonarteritic anterior ischemic optic neuropathy (NAION): Results of
the ischemic optic neuropathy decompression trial (IONDT). The Association for Research in
Vision and Ophthalmology. May 14 - 19, 1995. Ft. Lauderdale, Florida.
Does estrogen directly effect lacrimal gland function? The Association for Research in Vision
and Ophthalmology. May 14 - 19, 1995. Ft. Lauderdale, Florida.
Grave’s Ophthalmology and Alzheimer’s Disease. Los Alamitos Medical Center. June 19,
1995. Los Alamitos, California.
Ophthalmic Investigation. Progress in Thyroid Associated Ophthalmopathy. Allegheny
General Hospital. September 8 - 9, 1995. Pittsburgh, Pennsylvania.
Steroid responsive optic neuritis. William F. Hoyt Colloquium. December 7 - 8, 1995. San
Francisco, California.
CURRICULUM VITAE
PAGE 29
1996
1.
2.
3.
4.
5.
6.
7.
1997
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
1998
1.
2.
STEVEN E. FELDON, MD
In the thick of it. 28th Annual Frank B. Walsh Society Meeting, February 10 - 11, 1996. Salt
Lake City, Utah.
Familial nonarteritic ischemic optic neuropathy. North American Neuro-Ophthalmology
Society. February 11 - 15, 1996. Snow Bird, Utah.
Sweep visual evoked potential evaluation of visual function in Alzheimer’s dementia (poster).
North American Neuro-Ophthalmology Society. February 11 - 15, 1996. Snow Bird, Utah.
Familial Anterior Ischemic Optic Neuropathy. 19th Annual Alumni Residents Day
Conference. June 7 - 8, 1996. Doheny Eye Institute, Los Angeles, California.
Optic Neuropathies of Neurosurgical Significance. Second International Scull Base Congress
and the Seventh Annual Meeting of the North American Skull Base Society. June 29 - July 4,
1996. San Diego, California.
American Board of Ophthalmology exams. October 11 - 13, 1996. San Francisco, California.
Basic Neuro-Ophthalmology Course; Automated Perimetry Course. American Academy of
Ophthalmology. October 27 - 31, 1996. Chicago, Illinois.
Practical Neuro-Ophthalmology: Pupils, Papilledema and Palsies. Ophthalmology and ENT
for the Primary Care Physician. January 20 - 22, 1997. La Jolla, California.
Infectious Orbital Cellulitis and Paranasal Sinus Disease. North American NeuroOphthalmology Society. February 9 – 13, 1997. Keystone, Colorado.
Medical Management of Thyroid Related Orbitopathy in the Inflammatory Phase: Decision
Making. Jules Stein Eye Institute Postgraduate Seminar. April 11, 1997. Jules Stein Eye
Institute, Los Angeles, California.
Management of Graves’ Eye Disease. Topical Diagnosis of Visual Pathway Disease. Clinical
Update 1997: Neuro-Ophthalmology. May 7, 1997. University of California, Irvine,
California.
Current Management of Graves’ Ophthalmopathy. CT and MR Scan Interpretation for the
Ophthalmologist. Neuro-Ophthalmology Update. May 10, 1997. Doheny Eye Insitute, Los
Angeles, California.
Harris Visiting Professorship. June 13 – 14, 1997. University of Minnesota, Minneapolis,
Minnesota.
Thyroid Eye Disease. Orbital Cellulitis. Orbital Pseudotumors. Visiting Professor.
September 26 – 27, 1997. University of Washington, St. Louis, Missouri.
Arteriovenous Malformation. CME Conference. October 8, 1997. Torrance Memorial
Hospital Medical Center. Torrance, California.
Neuro-Imaging Skills Transfer Course; Automated Perimetry Course. American Academy of
Ophthalmology. October 26 - 30, 1997. San Francisco, California.
Electronic Medical Records. Visiting Professor. November 12 – 14, 1998. SUNY Stony
Brook Health Sciences Center, Stony Brook, New York.
Residents’ Annual All Day Clinical Conference. January 10, 1998. Doheny Eye Institute,
Los Angeles, California.
Current Management of Graves’ Ophthalmopathy. Neuro-Ophthalmology Update. March 14,
1998. Doheny Eye Insitute, Los Angeles, California.
CURRICULUM VITAE
PAGE 30
3.
4.
5.
6.
7.
8.
9.
10.
1999
1.
2.
3.
4.
5.
6.
7.
8.
2000
1.
2.
3.
4.
STEVEN E. FELDON, MD
North American Neuro-Ophthalmology Society. March 21 – 24, 1998. Orlando, Florida.
Non-ischemic Anterior Optic Neuropathy. Graves’ Ophthalmopathy. Orbital Pseudotumor.
Transient Obscuration of Vision. Visiting Professor. March 29 – April 4, 1998. National
Taiwan University, Taipei, Taiwan.
American Board of Ophthalmology exams. June 5 – 7, 1998. San Francisco, California.
American Board of Ophthalmology exams. October 10 – 11, 1998. San Francisco,
California.
An Ice Test for the Diagnosis of Myasthenia Gravis: A Prospective Study. American
Academy of Ophthalmology. November 7 – 11, 1998. New Orleans, Louisiana.
Evaluation and Management of Ocular Trauma. Doheny Eye Institute, Los Angeles,
California. November 14, 1998.
Soft Tissue Involvement. VIth International Symposium on Graves’ Ophthalmology.
November 25 – 28, 1998. Amsterdam, The Netherlands.
Thyroid Ophthalmology. Drew University. December 7, 1992. Los Angeles, California.
Residents’ Annual All Day Clinical Conference. January 9, 1999. Doheny Eye Institute, Los
Angeles, California.
Pathophysiology of Graves’ Ophthalmopathy: Implications for Clinical Management; Orbital
Cellulitis: An Update; Compressive and Infiltrative Optic Neuropathies: Management
Considerations; Familial Non Arteritic Anterior Ischemic Optic Neuropathy. 25th Annual
Frontiers in Ophthalmology. February 25 – 27, 1999. Scottsdale, Arizona.
North American Neuro-Ophthalmology Society Meeting. March 14 – 18, 1999. Snowmass,
Colorado.
Marketing Ophthalmology in a Managed Care Environment. Practice Management CME
Series. May 1, 1999. Doheny Eye Institute, Los Angeles, California.
Annual Alumni Residents Day Conference. June 11 – 12, 1999. Doheny Eye Institute, Los
Angeles, California.
Nystagmus; Supranuclear Disturbances of Gaze; Infra-nuclear Disorders of Gaze; Neuroradiology for the Ophthalmologist. Stanford Basic Science Course. July 29, 1999. Stanford
Medical Center, Stanford, California.
Graves’ Ophthalmopathy; Ischemic Optic Neuropathy: Update; Orbital Cellulitis: Diagnosis
and Management. 33rd National Ophthalmology Congress. October 2 – 6, 1999. Izmir,
Turkey.
LEO Update Course in Neuro-Ophthalmology, Part I and Part II. American Academy of
Ophthalmology. October 22 – 28, 1999. Orlando, Florida.
Residents’ Annual All Day Clinical Conference. January 8, 2000. Doheny Eye Institute, Los
Angeles, California.
Frank Walsh Society Meeting. March 25 – 26, 2000. Lake Champlain, Canada.
North American Neuro-Ophthalmology Society Meeting. March 27 – 30, 2000. Montreal,
Canada.
Annual Alumni Residents Day Conference. June 9, 2000. Doheny Eye Institute, Los
Angeles, California.
CURRICULUM VITAE
PAGE 31
5.
6.
STEVEN E. FELDON, MD
Medical Missionary. October 9 – 16, 2000. Armenia.
Basic Neuro-Ophthalmology Part I and Part II, Skills Transfer Course. American Academy
of Ophthalmology. October 22 – 25, 2000. Dallas, Texas.
2001
1. Transantral decompression for Graves’ disease. Research Study Club Midwinter Conference.
January 26 – 27, 2001. Los Angeles, California.
2. North American Neuro-Ophthalmology Society Meeting. March 17 – 22, 2001. Palm Springs,
California.
3. Diagnosis and Management of Optic Nerve Sheath Meningioma. Annual Postgraduate seminar
and thirty-second Jules Stein lecture. March 30–31, 2001. Los Angeles, California.
4. Electronic Medical Records, Making Use of the Internet in Your Practice: Is there anything for
me and my office, Arteritic AION-Biopsy? When? Where? Both Sides? American Academy of
Ophthalmology. November 10-14, 2001. New Orleans, Louisiana.
2002
1. Management of diplopia in Graves’ Ophthalmopathy, Optic neuritis 4th nerve palsy. Medical
Missionary. March 1-10, 2002. Hyderabad, India.
2. Thyroid Eye Disease: Management and Mimickers, Management of Idiopathic Intracranial
Hypertension. Greater New York Ophthalmology Clinical Lecture Series. April 3, 2002. New
York, NY.
3. Management of Ocular Motility Problems Due to Graves’ Ophthalmopathy, Diagnosis and
Mangement of Giant Cell Arteritis. Rochester Ophthalmology Conference. May 17-18, 2002.
Rochester, N. Y.
2003
1. Compensation. Association of University of Professors of Ophthalmology. January 30February 1, 2003. Indian Wells, California.
2. Thyroid Eye Disease, Optic Neuritis Update, Temporal Arteritis, Traumatic Optic Neuropathy.
The Chicago Annual Clinical Conference. April 25-26, 2003. Chicago, IL.
3. Thyroid-related Eye Disease: what is it and how is it treated?. Annual Doheny Days
Conference. June 13-14, 2003. Doheny Eye Institute. Los Angeles, California.
4. Arteritic AION, Medical Missionary. October 12-18, 2003. Yerevan, Armenia.
5. Ischemic Optic Neuropathy, University of Buffalo Lecture, Buffalo, NY. November 6, 2003.
6. Electronic Medical Records for Ophthalmology, Idiopathic Intracranial Hypertension, Giant
Cells Arteritis, Ocular Motility Disturbances in Graves’ Ophthalmopathy. Syracuse Post-Grad
Review Course. Syracuse, NY. December 2003.
2004
1. Technology to Trends, International Eye Health Symposium. Electronic Medical Records for
Ophthalmology development of a New Hand-Held Tonometer. Hyderabad, India. April 2004.
2. N.Y. Ophthalmological Society. Thyroid Eye Disease: Diagnosis. Columbia University. New
York, NY. May 2004.
3. The Smith-Kettlewell Eye Research Institute. An in Vitro Model for the Study of Graves’
Ophthalmopathy. San Francisco, CA. June 2004.
CURRICULUM VITAE
PAGE 32
STEVEN E. FELDON, MD
4. The Cleveland Clinic Foundation. Advances in Strabismus and Neuro-Ophthalmology.
Cleveland, OH. April 2004.
5. The University of Alabama at Birmingham. Experimental Models of Graves’ Ophthalmopathy.
Birmingham, AL. January 2004.
2005
1.
2.
3.
2006
1.
2.
3.
4.
5.
2007
1.
North Shore-LIJ Grand Rounds Visiting Professor. “Update on Graves’ Ophthalmopathy”.
March 2005.
Grand Rounds Guest Lecture Series. The Institute of Ophthalmology and Visual Science.
Ischemic Optic Neuropathy Newark, NJ. “Anterior Ischemic Optic Neuropathy: An Update.”
April 2005.
American Ophthalmological Society 141st Scientific Session. Discussion: Local corticosteroid
treatment of eye lid and orbital and xanthogranuloma – by Elner, et al. Sea Island, Georgia.
May 2005.
The Association for Research in Vision and Ophthalmology. “Visual Fields in the Ischemic
Optic Neuropathy Decompression Trial (IONDT): baseline and change over time”. Ft.
Lauderdale, FL. April 2006.
The 51st Annual Ophthalmology Conference. “Update on Thyroid Eye Disease”. Rochester,
NY. May 2006.
Association for the Blind and Visually Impaired (ABVI) Goodwill Industaries. “Preventing of
Eye Disease. June 2006.
Massachusetts Eye & Ear Infirmary Grand Rounds Visiting Professor. “Non-Arteritic
Ischemic Optic Neuropathy. Oct. 2006.
Jules Stein Eye Institute. Graves’ Disease International Symposium. “Talking with TED:
Roadmap for Research in Thyroid Eye Disease. Nov. 2006
An Update on Thyroid-associated Eye Disease. Scientific Committee. Hyderabad, India.
January 2007.